Article
Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
Thrombosis and haemostasis - 1 Jul 2015
van den Boogaard Florry E, van 't Veer Cornelis, Roelofs Joris J T H, Meijers Joost C M, Schultz Marcus J, Broze George J, van der Poll Tom
Abstract excerpt
Streptococcus (S.) pneumoniae is the most common causative pathogen in community-acquired pneumonia. Coagulation and inflammation interact in the host response to infection. Tissue factor pathway inhibitor (TFPI) is a natural anticoagulant protein that inhibits tissue factor (TF), the main activator of inflammation-induced coagulation. It was the objective of this study to investigate the effect of endogenous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
